Phytochemical composition of Potentilla anserina L. analyzed by an integrative GC-MS and LC-MS metabolomics platform
- First Online:
- Cite this article as:
- Mari, A., Lyon, D., Fragner, L. et al. Metabolomics (2013) 9: 599. doi:10.1007/s11306-012-0473-x
- 3k Downloads
Potentilla anserina L. (Rosaceae) is known for its beneficial effects of prevention of pre-menstrual syndrome (PMS). For this reason P. anserina is processed into many food supplements and pharmaceutical preparations. Here we analyzed hydroalcoholic reference extracts and compared them with various extracts of different pharmacies using an integrative metabolomics platform comprising GC-MS and LC-MS analysis and software toolboxes for data alignment (MetMAX Beta 1.0) and multivariate statistical analysis (COVAIN 1.0). Multivariate statistics of the integrated GC-MS and LC-MS data showed strong differences between the different plant extract formulations. Different groups of compounds such as chlorogenic acid, kaempferol 3-O-rutinoside, acacetin 7-O-rutinoside, and genistein were reported for the first time in this species. The typical fragmentation pathway of the isoflavone genistein confirmed the identification of this active compound that was present with different abundances in all the extracts analyzed. As a result we have revealed that different extraction procedures from different vendors produce different chemical compositions, e.g. different genistein concentrations. Consequently, the treatment may have different effects. The integrative metabolomics platform provides the highest resolution of the phytochemical composition and a mean to define subtle differences in plant extract formulations.
KeywordsMedicinal plantsMetabolomicsGC-MSLC-MSFlavonoidsGenisteinMass accuracy precursor alignment (MAPA)
Potentilla anserina L. (silverweed) belongs to the family of Rosaceae and its extracts have been used for a long time in traditional medicine. The gynecological indication for P. anserina is based on pharmacological studies showing that the herb increases the tonus of the isolated uterus in various animal species (Schulz et al. 1998). Additionally, extracts of the aerial and/or underground parts have been applied in traditional medicine for the treatment of inflammations, wounds, certain forms of cancer, infections due to bacteria, fungi and viruses, diarrhoea, diabetes mellitus and other ailments (Bundesgesundheitsamt 1985, 1990). Tomczyk and Latté report that P. anserina (aerial parts or the whole plant) and other Potentilla species are generally used to prepare homeopathic medications (Tomczyk and Latté 2009) according to homeopathic pharmacopoeias like Homeopathic Pharmacopoeia of the United States (HPUS) and German Homeopathic Pharmacopoeia (HAB) (Hiller 1994). For this reason P. anserina is processed into many food supplements and pharmaceutical preparations such as teas, tinctures, capsules, tablets, and juice and is consumed by women in order to prevent the symptoms of pre-menstrual syndrome (PMS).
2 Materials and methods
Chloroform, ethanol (absolute), methanol, n-butanol, petroleum ether (HPLC grade), were purchased from Sigma-Aldrich (Vienna, Austria) in Chromasolv® grade as well as pyridine over molecular sieve (GC-grade). Acetonitrile (HPLC grade) and formic acid were obtained from Merck (Darmstadt, Germany). Chlorogenic acid was purchased from Roth (Graz, Austria), genistein, quercetin-3-O-glucoside and D-sorbitol, β-alanine, arabinose, asparagine, citric acid, d(-)quinic acid, fructose, glucose, glyceric acid, glycerol, glycine, l-alanine, l-aspartic acid, l-leucine, l-serine, l-threonine, malic acid, mannitol, myo-inositol, phenylalanine, pinitol, proline, sucrose, trehalose, valine and, xylose were purchased from Sigma-Aldrich (Vienna, Austria), kaempferol-3-O-glucoside was obtained from Extrasynthese (Genay, France). Myricetin-3-O-rhamnoside and quercetin-3-O-glucuronide were isolated by size exclusion chromatography and semipreparative HPLC with UV detection from the hydroalcoholic extract of P. anserina and their structures were characterized by 1D and 2D nuclear magnetic resonance (NMR). For derivatization methoxyamine hydrochloride and N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) were purchased from Sigma-Aldrich (Vienna, Austria), as well as retention index marker alkanes (all even C10–C40). HPLC grade water (18.2 mΩ) wËas prepared using a Millipore Milli-Q purification system (Millipore Corp., Bedford, MA, USA).
2.2 Plant material
Potenilla anserina air-dried plant parts were purchased from Minardi s.r.l. (Bagnacavallo, Ra, Italy). 500 g of whole plant parts were extracted with petroleum ether three times. After filtration the raw material was extracted three times with chloroform and finally with 70 % EtOH following the same procedure performed with petroleum ether. The collected alcohol-aqueous extract (PanserinaUniSa) was dried under vacuum.
A second extract (PanserinaUniVie) was prepared using a grinding mill system MM400 from Retsch (Haan, Germany). 250 mg of ground plant material was extracted with 25 mL of a solution of methanol/chloroform/water (2.5:1:0.5, v:v:v) (Weckwerth et al. 2004) and then vortexed for 10 min followed by 8 min incubation. The sample was then centrifuged for 4 min at 3,400×g and the supernatant was separated from the pellet. 5 mL of distilled water were added to the supernatant, followed by 10 s shaking on a vortex and 2 min centrifugation at 3,400×g. The alcoholic-aqueous phase was dried under vacuum.
Five mother tinctures were acquired from five drugstores (# 1, 2, 3, 4 and 5) in Vienna. For each of them 1 mL was dried under vacuum.
All samples were analyzed by gas chromatography and liquid chromatography coupled to mass spectrometry. For data analysis (see below) all sample injections were normalized against corresponding extract dry weights.
2.3 Extract derivatization and GC-MS analysis
The protocol for GC-MS analysis was performed according to Weckwerth et al. (2004) with slight changes. Before derivatization 25 μL of 13C-d-sorbitol (0.02 μg μL−1) were added to all samples as internal standard. Samples were derivatized in two steps. First 20 μL methoxyamination mixture (40 mg mL−1 methoxyamine hydrochloride in dry pyridine) were added and incubated for 90 min at 30 °C in a thermo shaker. Then 80 μL of N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) silylation mixture including retention index marker were added (30 μL of alkane mixture (even-numbered C10-C40-alkanes, each 50 mg L−1) and incubated for 30 min at 37 °C.
Derivatized samples were centrifuged and 50 μL of supernatant was transferred to GC-vials with micro inserts and closed with crimp caps.
GC-MS analyses were performed on a ThermoFisher Trace gas chromatograph coupled to a Triple Quadrupole mass analyzer (Thermo Scientific TSQ Quantum GC™, Bremen, Germany). 1 μL of derivatized sample was injected at a constant temperature of 230 °C in splitless mode with a deactivated Siltek liner (Restek). Each sample was measured three times with the same conditions to get technical replicates.
GC separation was performed on a HP-5MS capillary column (30 m × 0.25 mm × 0.25 μm) (Agilent Technologies, Santa Clara, CA), at a constant flow 1 mL min−1 helium. Initial oven temperature was set to 70 °C and hold for 1 min, followed by a ramp to 76 °C at 1 °C min−1 and a second ramp at 6 °C min−1 to 350 °C hold for 1 min. Transfer line temperature was set to 340 °C and post run temperature to 325 °C for 10 min.
Mass analyzer was used in full scan mode scanning a range from m/z 40–800 at a scan time of 250 ms. Electron impact (EI) ionization was used at 70 eV and ion source temperature was set to 250 °C.
Compounds occurring in P. anserina hydroalcoholic extracts measured by GC/EI(TSQ)MS
1. Glycolic acid (2TMS)
2. Alanine (2TMS)a
3. Unknown 1
4. Unknown 2
5. Valine (2TMS)a
6. Leucine (2TMS)a
7. Glycerol (3TMS)a
8. Proline (2TMS)a
9. Glycine (3TMS)a
10. Succinic acid (2TMS)
11. Glyceric acid (3TMS)a
12. Serine (3TMS)a
13. Threonine (3TMS)a
14. Malic acid (3TMS)a
15. Pyroglutamic acid (2TMS)
16. Threitol or erythritol (4TMS)
17. Aspartic acid (3TMS)a
18. 4-amino butyric acid (3TMS)
19. Unknown 3
20. Unknown 4
21. Phenylalanine (2TMS)a
22. Asparagine (3TMS)a
23. Arabinose (1MeOx) (4TMS)a
24. Xylose (1MeOx) (4TMS)a
25. Xylitol or ribitol (5TMS)
26. 2-desoxy-pentos-3ylose (2MeOx)(2TMS)
27. Unknown 5
28. Lyxonic acid (5TMS)
29. Shikimic acid (4TMS)
31. Citric acid (4TMS)a
32. Carbohydrate (5TMS)
33. Glucopyranoside (5TMS)
34. Pinitol (5TMS)a
35. Quinic acid (5TMS)a
36. Fructose (1MeOx) (5TMS)a
37. Hexose (5TMS)
38. Glucose (1MeOx) (5TMS)a
39. Mannitol (6TMS)a
40. Unknown (inositol isomer)
41. Glucopyranoside (5TMS)
42. Carbohydrate (glucopyranoside 5TMS)
43. Gluconic acid (6TMS)
44. Unknown 6
45. Myo-inositola (6TMS)
46. Sucrose (8TMS)a
47. Trehalose (8TMS)a
48. Isomaltose (1MeOx) (8TMS)
49. Melibiose (1MeOx) (8TMS)
50. Unknown 7
51. Unknown 8
52. Unknown 9
53. Unknown 10
2.4 NanoLC-Orbitrap-MS/MS analyses
For all the samples described in the plant material section, 0.12 μg μL−1 water/acetonitrile (95:5, v:v) 0.1 % formic acid solutions were prepared and centrifuged at 13,000×g for 3 min. For each of them, 5 μL were used for LC-MS and MS/MS analysis in triplicates.
A 1D plus nanoUHPLC system (Eksigent, Dublin, Ireland) was equipped with an autosampler and the employed column was a Waters nanoAcquityHSS T3, 1.8 μm, 100 μm × 100 mm. The mobile phases were water 0.1 % formic acid (A) and 90 % acetonitrile in water 0.1 % formic acid (B) at a flow rate of 500 μL min−1. The LC conditions were 5 % B during 0–3 min, a linear increase from 5 to 20 % B during 3–25 min, from 20 to 40 % B during 25–40 min and from 40 to 50 % B during 40–55 min, finally from 50 to 95 % B during 55–63 min followed by 15 min of maintenance. A Thermo Electron LTQ-Orbitrap XL mass spectrometer equipped with a nano electrospray ion source (ThermoFisher Scientific, Bremen, Germany) and operated under Xcalibur 2.1 version software, was used in positive ionization mode for the MS analysis using data-dependent automatic switching between MS and MS/MS acquisition modes. The instrument was calibrated using the manufacturer’s calibration standards. The scan was collected in the Orbitrap at a resolution of 30, 000 in a m/z range of 150–1,800. In order to achieve even higher mass accuracy a lock mass option was enabled in both MS and MS/MS mode and the cyclomethicone N5 ions generated in the electrospray process from ambient air (m/z = 371.101230) were used for internal recalibration in real time. This allowed mass accuracies of <1 ppm. The capillary voltage was 4.5 kV, the tube lens offset 160 V and the capillary temperature was set at 180 °C, no sheath gas and auxiliary gas were used.
Data deconvolution was performed with a modified ProtMAX version called MetMAX Beta 1.0 which provides mass accuracy precursor alignment of selected m/z signals in the LC-MS profile (Hoehenwarter et al. 2008). As for GC-MS, the COVAIN tool (Sun and Weckwerth 2012) was used for statistical analyses of the LC-MS data as well.
2.5 MetMAX Beta 1.0 processing and COVAIN analysis of LC-MS data
Raw data files were converted to mzXml format using the MassMatrix mass spectrometric data file conversion tool version 3.9 from the Case Western Reserve University (Cleveland, Ohio, USA; http://www.massmatrix.net/). MetMAX Beta 1.0 was used to process the mzXml files, generating a matrix of precursor ion intensities (Hoehenwarter et al. 2008). Each column vector contains the quantities of selected metabolites; each row vector describes the abundance of a respective metabolite ion over the entire set of analyses. Each column was normalized to its total spectral count. The .csv data table resulting from MetMAX Beta 1.0 were imported into COVAIN for statistical analysis (Sun and Weckwerth 2012). The values were then log-transformed. Principal component analysis (PCA) was performed for decomposition and visualization of data. The components of the column vectors, i.e. the precursor m/z, constitute the loadings of the independent components, and were identified by matching their retention times and mass spectra with those of the corresponding reference standards (see supplementary data).
3 Results and discussion
3.1 Qualitative and quantitative nanoLC-Orbitrap-MS/MS analyses of P.anserina crude extract
Retention time (Rt), precursor ions and product ions (for qualitative confirmation of the compound), of compounds occurring in P. anserina hydroalcoholic extracts by nanoLC-Orbitrap-MS/MS
Precursor ion (m/z)
Product ions (m/z)
1. Chlorogenic acidb
2. Chlorogenic acid isomer
3. Myricetin 3-O-glucuronidea
Kombal and Glasl (1995)
4. Quercetin -3-O-sambubiosidea
Kombal and Glasl (1995)
5. Myricetin 3-O-rhamnosideb
Kombal and Glasl (1995)
6. Quercetin 3-O-glucosideb
Kim et al. (2004)
7. Quercetin 3-O-glucuronideb
Merfort and Wendisch (1988)
8. Quercetin 3-O-xylosidea
Zou et al. (2002)
9. Quercetin pentoside
10. Kaempferol 3-O-glucosideb
Kim et al. (2004)
11. Rutin (mass bank match)
Wang et al. (1999)
Kombal and Glasl (1995)
13. Acacetin-7-O-rutinoside (mass bank match)
14. Kaempferol 3-O-rutinoside (mass bank match)
489; 471; 453;435; 409
489; 471; 453;407; 316
253; 243; 225;215; 197; 159; 153; 145
The analysis of the HR-ESI-MS spectrum of compound 2 suggested it as a chlorogenic acid isomer showing the diagnostic [M + Na]+ ion at m/z 377.0477 along with the [M + H]+ ion at m/z 355 with a shift of 6 min in Rt. In particular, by the analysis of the tandem mass spectrum of the [M + H]+ ion, compound 2 showed product ions accounting for the same composition of chlorogenic acid, originated by the neutral loss of 192 a.m.u. (Table 2; Fig. 2).
Full positive HR-ESI-MS profile of compound 13 was in agreement with a di-glycosylated acacetin structure, showing the diagnostic [M + H]+ ion at m/z 593.1864. The analysis of the ESI-MS2 spectrum of 13 allowed to determine the presence of a deoxy-hexose unit, besides product ion originated by the sequential neutral losses of 146 a.m.u leading to [(M-146) + H]+ion at m/z 447 and of 162 a.m.u. leading to [(M-146-162) + H]+ ion at m/z 285 corresponding to the acacetin-aglycone (Table 2; Fig. 2). For identification, the MS2 spectrum of compound 13 was compared to that of acacetin 7-O-rutinoside present in Mass Bank library.
The HR-ESI-MS spectrum of compound 14 assigned it to a diglycosylated kaempferol according to the presence of the [M + H]+ ion at m/z 595.1445. The tandem mass experiment on the [M + H]+ ion allowed to observe a product ion at m/z 449, due to the neutral loss of one deoxy-hexose 146 a.m.u. and a product ion at m/z 287, due to the neutral loss of one hexose unit and corresponding to a kaempferol-aglycon (Table 2; Fig. 2). Identification of compound 14 as kaempferol 3-O-rutinoside was done by matching its tandem mass spectra with that of Mass Bank (data not shown).
According to the HPLC-ESIMS data, the positive ESIMS spectrum of compound 17 showed a minor [M + H]+ ion peak at m/z 271.0601. Interestingly, the MS/MS spectrum of the [M + H]+ ion showed a fragmentation pattern very similar to what was proposed by Lee et al. (2002) for the isoflavone genistein. By comparing compound 17 Rt and MS/MS spectra to that of the corresponding commercial standard we confirmed it as genistein (Table 2; Fig. 2). Although the presence of genistein and its glycosides is already reported in the family of Rosaceae (Jung et al. 2002; Lee et al. 2002; Ismail and Hayes 2005; Tohno et al. 2010) and in Potentilla genus (Şöhretoğlu and Sterner 2011), this is the first time that this isoflavone is reported in this particular species.
For compounds 15 and 16 no unambiguous identification was possible. These compounds could be isorhamnetin derivatives with two glucuronide units according to their fragmentation pattern in MS/MS. The structural elucidation is planned in future studies.
3.2 Multivariate statistical analysis of Potentilla anserina crude and commercial extracts from different pharmacies
In order to carry out a comparative study between our P. anserina reference extract and five hydroalcoholic extracts from different pharmacy vendors all were analyzed with the same GC- and LC-MS conditions.
In both cases, our results revealed that qualitative profiles of mother tinctures seem to be very similar to that of the crude extract shown in supplementary Fig. 1 and 2.
To obtain a more comprehensive view of the LC-MS data a second PCA was applied to a dataset pre-processed by MetMAX Beta 1.0. After calculating the intensity mean, standard deviation and the relative standard deviation (RSD) among three technical replicates for all the peaks, the RSD mean was estimated for each peak and only those with a value <25 were selected for multivariate statistical analysis. By application of this method we selected 1,866 variables for PCA (Fig. 3c). Both plots, Fig. 3b and c, are very similar indicating the robustness of the LC-MS MetMAX Beta 1.0 approach.
Eventually the integration of GC-MS and LC-MS data into one data matrix for PCA showed the clear separation of the hydroalcoholic extracts PanserinaUniSa, PanserinaUniVie and #2 from the other extracts (Fig. 4). The loadings (supplementary Table 1) of this PCA plot demonstrates the different importance of either GC-MS or LC-MS compounds for sample classification. Synergistic effects of data integration for sample pattern recognition were also recently revealed in studies for the integration of primary and secondary metabolism as well as due to the integration of metabolomic and proteomic data (Morgenthal et al. 2005; Wienkoop et al. 2008; Doerfler et al. 2012). The integration of GC-MS and LC-MS data enables the search of precursor-product correlations in biosynthetic pathways. This was recently shown in the study by Doerfler et al. (2012) using Granger causality analysis to reveal the biosynthetic interface of primary and secondary metabolism.
3.3 Comparative analysis of genistein in extracts from different pharmacy vendors
In this study we report for the first time a high resolution LC-MS method for the evaluation of the chemical composition of P. anserina polar extracts. By this accurate and sensitive analysis we revealed the presence of compounds never reported for P. anserina. Especially important is the identification of the isoflavone genistein which is considered as an active compound in the estrogenic therapy. This fact may explain the positive effect of P. anserina polar extracts in the treatment of premenstrual syndrome diseases.
Moreover our results showed the advantages of applying an integrated LC-MS, GC-MS metabolomics platform for the evaluation of the similarities between medicinal plant extracts and their commercial products. The unbiased assignment of m/z features to sample classification using Mass Accuracy Precursor Alignment (MAPA) and the corresponding MetMAX algorithm in combination with multivariate statistics [MAPA and COVAIN; (Hoehenwarter et al. 2008; Sun and Weckwerth 2012)] opens up opportunities to identify novel compounds in the medicinal plant extracts which were previously not detected. We have discussed two of these unknowns and will address these investigations in more detail in future studies.
We thank the University of Vienna for generous support. DL is supported by the FWF grant P23441-B20. We thank the anonymous reviewers for very helpful suggestions
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.